Sign Up to like & get
recommendations!
1
Published in 2022 at "ChemBioChem"
DOI: 10.1002/cbic.202200012
Abstract: Small‐molecule splicing modulators exemplified by an FDA‐approved drug, risdiplam, are a new pharmacological modality for regulating the expression and stability of splice isoforms. We report a CRISPR‐mediated enzyme fragment complementation (EFC) assay to quantify the…
read more here.
Keywords:
complementation;
efc assay;
stability splice;
crispr mediated ... See more keywords